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STIM1 is the only currently known intracellular calcium sensor that functions as the calcium influx regulator controlling immune
cell activation. STIM1 function in immune cell calcium signalling has been studied extensively; however, its role in microglia,
innate immune cells in brain, has not been fully understood. Here, we report that STIM1−/− murine microglia lost store-operated
calcium influx and displayed aberrant immunological functions. Microglial functions regulated by chronic and global [Ca2+]i
changes were reduced significantly, including cytokine releases and opsonin-dependent phagocytosis. More dramatically, cellular
functions governed by Ca2+ regulation in local microdomains at the cell periphery, such as UDP-induced phagocytosis and ATP-
stimulated chemotactic migration, were severely reduced in STIM1−/− microglia. Interestingly, UDP-induced Orai1 mobilization
to the peripheral region was greatly attenuated in STIM1−/− microglia. Their chemotactic migration defect was reproduced in
vivo in embryonic brain; the aggregated number of STIM1−/− microglia in LPS- (lipopolysaccharide-) injected lesions was much
smaller than that in wild-type microglia. Furthermore, the neuron phagoptosis activities of activated microglia were significantly
diminished in the STIM1−/− microglia.These in vitro and in vivo results suggest that STIM1-mediated store-operated calcium entry
is important for the regulation of global [Ca2+]i changes which differentiates into active immune state of microglia, but it is more
crucial for the regulation of local [Ca2+] microdomains which mediates the acute motility of murine microglia.
1. Introduction
Microglia are resident macrophages in the brain that orches-
trate inflammatory responses. Microglia detect infection
sites, foreign material, and pathological alterations in the
brain [1, 2]. Pathological stimuli such as lipopolysaccharide
(LPS) activate microglia and induce several morphological
changes, including phagocytosis to remove cellular debris,
and secretion of chemicalmediators such as proinflammatory
cytokines, which propagate immunological activities [1]. LPS,
a representative immune function inducer ofmicroglia, binds
to the TLR4 receptor (toll-like receptor 4) in microglia
and induces cytokine secretion and phagocytosis, which
is dependent on a sustained increase of intracellular Ca2+
concentration ([Ca2+]i) [3–5]. LPS also induces a shift in the
microglial gene expression profile, which is mainly mediated
by theNFAT (Nuclear factor of activated T-cell) transcription
factor [6]. Activated microglia have different gene expression
profiles, secrete cytokines such as TNF-alpha and IL-6 and
have the enhanced opsonin-dependent phagocytotic activity
[6]. Chronic elevation of [Ca2+]i boosts phagocytosis and
migration via optimizing the related gene expressions, but
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UDP-mediated phagocytosis and ATP-induced chemotactic
migration are primarily regulated by local [Ca2+] in focal
microdomains at the edge of cells, such as the phagosome
or focal adhesion spot [7–9]. Injured neuronal cells leak
nucleotides, which activate several P2 receptors in microglia
[2, 10, 11]. P2X4 and P2X7, the most widely expressed P2X
subunits on microglia, are activated by ATP and form a
homomeric Ca2+-permeable channel [12, 13]. Microglia also
express P2Y receptors; particularly P2Y6 and P2Y12 are acti-
vated by UDP, then change [Ca2+]i via Gq-coupled signalling
pathways, and cause Ca2+ influx from the plasma membrane
[8, 10].
It is well known that Ca2+ influx through store-operated
calcium entry (SOCE) mediates sustained calcium increases
during activation of immune functions in microglia [5, 14].
Recently, STIM1 (stromal interaction molecule 1) and STIM2
(stromal interaction molecule 2) have been identified as
the only protein family that functions simultaneously as an
intracellular calcium storage sensor and as a regulator of
calcium influx from the extracellular environment. STIM1
is a type 1, single-spanning membrane protein with an EF
hand Ca2+-binding motif, which functions as the sensor of
ER (Endoplasmic reticulum)-luminal Ca2+ [15, 16]. Depletion
of ER-luminal Ca2+ stores induces a conformational change
in STIM1; then, the C-terminal transmembrane domain
binds and activates the plasma membrane store-operated
channel [SOC; Orai; or transient receptor potential channel
(TRPC)], which induce Ca2+ influx [17, 18]. However, Ca2+
influx through SOCE in microdomains was not studied in
microglia.
In the present study, we investigate the function of
STIM1-mediated SOCE in pathogen- or purinergic-mediated
microglial immune function using STIM1−/− mice, which
have complete depletion of STIM1. Experiments using pri-
mary cultured microglia indicated that innate immune func-
tions governed by chronic and global [Ca2+]i changes, such
as cytokine release and opsonin-dependent phagocytosis,
were reduced significantly in STIM1−/− microglia. Above all,
functions regulated by the local [Ca2+] microdomains at the
edge or periphery of cells, such asUDP-induced phagocytosis
and ATP-stimulated chemotactic migration were essentially
abolished in STIM1−/−microglia.Themigration impairments
of STIM1−/− microglia were also observed in the embryonic
brain in vivo. The number of aggregated STIM1−/− microglia
into the LPS-injected lesion for 24 hours was significantly
lower than the number of aggregated WT microglia into
the LPS-injected lesion. Furthermore, the neuron phago-
cytotic activity of microglia had significantly diminished
in STIM1−/− microglia. These in vitro and in vivo results
suggest that STIM1 is crucial for the regulation of local
[Ca2+]microdomains in peripheral region ofmicrogliawhich
mediates the process of acute motility of murine microglia.
2. Materials and Methods
2.1. Mice. STIM1+/− heteromice (C57BL/6 background) were
generated as previously described [19, 20]. The mice were
bred and maintained according to the Yonsei Medical Cen-
ter animal research requirements, and all procedures were
approved by the Committee on Animal Research at Yonsei
Medical Center (protocol number 2011-0112). Since STIM1−/−
mice die within 1 day after birth due to defect in the
circulatory system, 17 day embryos taken off from pregnant
STIM1+/− females mated with STIM1+/− male mice were used
to purify eachWTand STIM1−/−microglia. For themicroglial
migration assays in vivo, the brains of the same aged embryos
were used. Genomic DNA isolated from the embryo tail
was used for genotyping. Genomic DNA for genotyping
was extracted using prepGEM Tissue (PTI0200; ZyGEM,
Hamilton, New Zealand).
2.2. Isolation and Culture of Primary Mouse Microglial
Cells, Astrocytes, and Neurons. Primary cultures of mouse
microglia were prepared from the whole brain of an embry-
onic day 17 (E17) mouse. Each embryo tail was used for geno-
type analyses to identify WT and STIM1−/− microglia. Pri-
mary mixed cells that had been chemically and mechanically
dissociated of the whole brain were seeded in DMEM/F12
(1 : 1) culture medium. Cells were cultured at 37∘C in an
incubator (Thermo Fisher Scientific, Marietta, OH, USA)
humidified with 5% CO2. Cell confluency was achieved
after 3∼4 weeks. After 4 weeks, the primary mixed cells
of WT and STIM1−/− were used a mild trypsinization and
shaking method [19]. The upper cell layer of mixed cells was
removed in one piece by treatingwith trypsin 0.25% (1x) solu-
tion (SH30042.01; Hyclone Laboratories, Thermo Scientific,
Logan, UT, USA) diluted 1 : 4 in DMEM/F12 (1 : 1) culture
medium (Dulbecco’s modified Eagle medium, 11320-033;
Gibco, Life Technologies, Carlsbad, CA, USA) containing
10% fetal bovine serum (26140-079, Gibco, Life Technologies,
Carlsbad, CA, USA) and 1% penicillin-streptomycin (15140-
122; Gibco, Life Technologies, Carlsbad, CA, USA) for 20min
at 37∘C. The trypsin diluted 1 : 4 in DMEM/F12 was suc-
tioned and replaced with 12mL of new culture medium. The
remained pure microglial cells were attached to the bottom
of the T75 flask and were isolated by shaking the T75 flasks
of WT, STIM1−/− at 120 rpm (SLOS-20; Seoulin Bioscience,
Seoul, Korea) at 37∘C for 1 h. 12mL of each medium were
collected from each flasks, placed a cell strainer with 40𝜇m
pore size (352340; BD Falcon, San Jose, CA, USA), filtered
into a fresh 15-mL conical tube, and centrifuged at 4,000 rpm
at room temperature for 5min. Glial cells were grown at a
high density into 75 T flasks to extract puremicroglia at 7 to 9
days in vitro. After isolate microglia, the remaining cells were
maintained in astrocyte-conditionedmedium and remaining
microglia were depleted by adding 50mM L-leucine-methyl
ester (LME, Sigma Aldrich, St. Louis, MO, USA) for 4
hours. To culture the cortical neuron, the culture of cortical
neuron was prepared from 1 day postnatal pups (C57BL/6
strain) as described previously [1] with some modifications.
The cerebella were dissociated in Versene solution (1 : 5000)
and plated at 0.5 × 106 cells/cm2 in 24-well plates coated
with Laminin (10𝜇g/mL in serum-free DMEM). Cells were
incubated in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with heat-inactivated horse serum (5%), fetal
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calf serum (5%), 13mM glucose, 0.5mM HEPES buffer,
25mM KCl, and 2mM L -glutamine. Cells were maintained
at in a humidified atmosphere of 37∘C, 5% CO2/95% air. To
inhibit growth of nonneuronal cells, 7.5𝜇MAra-C (cytosine-
D-arabinoside, Sigma Aldrich, St. Louis, MO, USA) was
treated to the medium 48 h after plating. Cortical neuronal
cells were used at 9 days after primary culture in experi-
ment to ensure morphological and physiological maturity.
Cells purities were checked with immunostaining of anti-
GFAP antibody, anti-Iba1 antibody, and MAP antibody for
glial cells, microglia, and neuron, respectively. The numbers
of cells were counted with haemocytometer (Marienfeld,
Lauda-Ko¨nigshofen, Germany).
2.3. Ca2+ InfluxMeasurements in STIM1−/−Mice. Ca2+ influx
wasmeasured by recording [Ca2+]i with Fura-2-AM labelling
(F1201; Invitrogen, Molecular Probes, Eugene, Oregon, USA)
as described previously [17]. Briefly, WT and STIM1−/−
microglia grown on glass cover slips were loaded with cell-
permeable Fura-2-AM, and trapped Fura-2 fluorescence was
measured with a spectrofluorometer (Photon Technology
International, Birmingham, NJ, USA). Cells were perfused
with a solution containing 150mM NaCl, 5mM KCl, 1mM
MgCl2, 10mM glucose, 10mM HEPES (pH 7.4 adjusted with
NaOH) containing either 1-2mM CaCl2 or 0.5mM EGTA
(to chelate any Ca2+ in the solution). The osmolality of all
solutions was adjusted to 310 Osm with the major salt. The
Fura-2 ratio was recorded using dual-excitation wavelengths
at 340 and 380 nm, and emission wavelengths above 510 nm
were monitored. Cells were treated with 25 𝜇Mcyclopiazonic
acid (CPA;C1530, SigmaAldrich, St. Louis,MO,USA), which
inhibits the endoplasmic reticulum (ER) Ca2+-ATPase. Cells
were treated with 100 𝜇M uridine 5󸀠-(trihydrogen diphos-
phate) sodium salt (UDP; U4125, Sigma Aldrich, St. Louis,
MO, USA) or 50 𝜇M adenosine 5󸀠-triphosphate di(tris) salt
hydrate (ATP; A9062, Sigma Aldrich, St. Louis, MO, USA).
2.4. Immunocytochemistry. Primary cultured WT and
STIM1−/− microglia were seeded on glass cover slips into
24-well plates at 5 × 104 cells/well and incubated at 37∘C in
an incubator enriched with 5% CO2 atmosphere overnight.
Cells were treated with or without 1 𝜇M thapsigargin (TG;
T9033, Sigma Aldrich, St. Louis, MO, USA) for 5min, fixed
with 4% paraformaldehyde in phosphate-buffered saline
(PBS) (19943 1 LT; Affymetrix, Cleveland, Ohio, USA)
at room temperature for 10min, and then rinsed three
times with PBS. Cells were permeabilized by incubating
in permeabilization solution [0.1% Triton X-100, 1% horse
serum, and 1% bovine serum albumin (BSA) in PBS, pH
7.4] at room temperature for 10min, and then rinsed three
times with PBS. To avoid nonspecific antibody binding,
cells were treated with blocking solution (5% horse serum,
1% BSA, 0.1% gelatin, and 0.001% sodium azide in PBS,
pH 7.4) at room temperature for 30min. Immunostaining
was performed in blocking solution using 1 : 100 dilution
of anti-Orai1 (D-15) (sc-74776; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) or 1 : 100 dilution of anti-STIM1
(610954; BD Biosciences, 1 : 100) as primary antibodies and
the appropriate secondary antibodies tagged with Alexa
Fluor-FITC or Alexa Fluor-rhodamine. Nuclei were stained
with 5 𝜇g/mL 4󸀠,6-diamidino-2-phenylindole (DAPI; D3571,
Invitrogen, Molecular Probes, Eugene, Oregon, USA). The
coverslips were rinsed, mounted with fluorescent mounting
medium (S3023, Dako, Glostrup, Denmark), and cells were
visualised on a confocal microscope (LSM 710 controlled
with Zen software; Carl Zeiss, Jena, Germany).
2.5. ELISA Assay. WT and STIM1−/− microglia were seeded
into 6-well plates at 2 × 106 cells/well and incubated at 37∘C
overnight.Then, cells were treated with or without 100 ng/mL
LPS and incubated at 37∘C in an incubator enriched with 5%
CO2 atmosphere for 24 h. The next day, supernatants were
assayed for levels of TNF-𝛼 and IL-6 using an ELISA kit
(430901 and 431301, resp.; BioLegend, San Diego, CA, USA)
according to the manufacturer’s instructions. Cytokine levels
in LPS-activated microglia were analysed for 30min (at 5-
min intervals) using the kinetic method and a VersaMax
spectrophotometer plate reader (Molecular Devices, Sunny-
vale, CA, USA) at 650 nm.
2.6. Phagocytosis Assay. WT and STIM1−/− microglia were
seeded into 12-well plates at 3 × 105 cells/well and incubated
at 37∘C overnight. Then, cells were treated with or without
100 ng/mL lipopolysaccharides from Escherichia coli 0111:B4
(L4391, Sigma Aldrich, St. Louis, MO, USA) and incubated at
37∘C in an incubator enriched with 5% CO2 atmosphere for
24 h. LPS-activated microglia were treated with BioParticles
Fluorescent Particles (conjugated with Alexa Fluor 488; E-
13231, Invitrogen, Molecular Probes, Eugene, Oregon, USA)
and incubated at 37∘C in an incubator enriched with 5%
CO2 atmosphere for 2 h, and then cells were rinsed three
times with PBS. To quench the particle fluorescence, cells
were treated with 0.4% trypan blue stain (15250-061, Gibco,
Life Technologies, Carlsbad, CA, USA) at room temperature
for 2min, and then cells were rinsed three times with PBS.
Cells were fixed with 4% paraformaldehyde in PBS at room
temperature for 10min, and then rinsed three times with
PBS. Nuclei were stained with 5 𝜇g/mL DAPI. Cells were
visualised on an inverted fluorescence microscope (IX73-
F22PH, Olympus), and fluorescence intensity was quantified
with MetaMorph software (Molecular Devices, Sunnyvale,
CA, USA). Flow cytometry experiments were conducted
as follows. WT and STIM1−/− microglia were seeded into
12-well plates at 3 × 105 cells/well and incubated at 37∘C
overnight. Then, cells were treated with or without 100𝜇M
UDP and incubated at 37∘C in an incubator enriched with 5%
CO2 atmosphere for 20min. UDP-activated microglia were
treated with BioParticles Fluorescent Particles as described
above. Cells were rinsed three times with PBS, treated with
0.05% trypsin-EDTA (25300-062, Gibco, Life Technologies,
Carlsbad, CA, USA) at 37∘C for 10min in a CO2-enriched
incubator, and then cells were harvested by centrifugation
at 2,000 rpm at 4∘C for 5min. Supernatant was removed,
500𝜇L ice-cold serum-free medium was added, and cells
were resuspended. Cells were held on ice and analysed by flow
cytometry using BD FACSVerse (BD Biosciences, Franklin
Lakes, NJ, USA) and a total gated cell number of 10,000 cells.
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Flow cytometry data were analysed with FlowJo software
(Treestar, Ashland, OR, USA).
2.7. In Vitro Chemotaxis Assay. Analysis of microglial migra-
tion was performed in triplicate using chemotaxis chambers
(101-8, Neuro Probe, Gaithersburg, MD, USA) as previously
described [13, 21]. Polycarbonate filters with 8-𝜇mpores were
coated with 10 𝜇g/mL fibronectin (F0895, Sigma Aldrich,
St. Louis, MO, USA) in PBS at room temperature for
1 h. The lower chambers were filled with 29 𝜇L of serum-
free DMEM-F12 media containing 50𝜇M ATP. The dry
fibronectin-coated filter was installed to separate the lower
chambers from the upper chambers.Then,WT and STIM1−/−
microglia were seeded into the upper chambers at 4 × 104
cells/well in 20𝜇L serum-free DMEM-F12, and chambers
were incubated at 37∘C in an incubator enriched with 5%
CO2 atmosphere for 15, 30, 60, and 90min. After incubation,
the chemotaxis chambers were disassembled and filters were
removed. Microglial cells in the lower chambers were stained
with tomato lectin (conjugated with DyLight 594, 1 : 200
dilution, Vector Labs, Carlsbad, CA, USA), nuclei were
stained with 5 𝜇g/mL DAPI at room temperature for 10min,
and then cells were rinsed three times with PBS. Cells that
had migrated to the lower chambers were visualised and
counted using an inverted fluorescent microscope (IX73-
F22PH, Olympus, Tokyo, Japan). The total number of cells
stained withDAPI was quantified usingMetaMorph software
(Molecular Devices, Sunnyvale, CA, USA).
2.8. Microinjection of Embryonic Mouse Brain In Vivo. We
used microinjection to target specific regions of embryonic
mouse brain in vivo as previously described [22]. Nanoliter
2000 microinjector and capillary glass (3.5 inches) (WPI,
Sarasota, FL, USA) were used as injection tools. Timed
pregnant STIM1+/− hetero female mice carrying embryonic
day 17 (E17) embryos were anesthetised with Isoflurane and
placed on a heating pad. Embryonic mice in utero were
injected with 30 nL of LPS mixed with 4% methylene blue
(66720; Sigma Aldrich, St. Louis, MO, USA). The final
concentration was 12 ng of LPS per one embryo in utero.
The mother was sutured and recovered on a warming pad
for 1 h, and then moved back to her home cage. After
24 h, the mother was reanesthetized with Isoflurane and the
abdominal incision was reopened to approach the embryos.
After the embryos were taken out of the utero, the mother
was inevitably sacrificed. Embryonic whole brains were fixed
with 10% formalin at 4∘C overnight. Then, the tissue was
transferred to 3M sucrose in PBS solution and incubated
at 4∘C until the tissue sinks to the bottom of the tube (a
couple of hours). This sucrose-infiltration is necessary for
tissue cryopreservation. The fixed embryo brain tissue was
used for cryosectioning 10 𝜇M thick slices, and embryo tails
were used for genotype analyses. Sections of embryonic WT
and STIM1−/− brains were stained in blocking solutions with
anti-Iba1 (1 : 200 dilution; 019-19741, Wako, Osaka, Japan), an
antibody specific for microglia, and a secondary antibody
labelled with Alexa Fluor 488 (Invitrogen, Molecular Probes,
Eugene, Oregon, USA) and then rinsed three times with
PBS. Nuclei were stained with 5 𝜇g/mL DAPI. After rinsing,
coverslips were mounted with fluorescent mountingmedium
(S3023, Dako, Glostrup, Denmark) and visualised on a
confocal microscope (LSM 710 controlled with Zen software,
Carl Zeiss, Jena, Germany).Three brains ofWTand STIM1−/−
embryonic mice were used for the experiments. The brain
slices were illustrated using a tile scan mode to obtain the
larger images of the entire brain. Among the larger images,
the images which showed the injected legion with methylene
blue were selected for counting the aggregated microglia and
the highest number of aggregating microglia were used for
summary.The total numbers of cells in lesion and counterpart
areas were measured by computer vision using MetaMorph
software.
2.9. Microglial Phagoptosis of Neurons. Normal neurons were
cultured in the bottomdish of transwell plates to induce dam-
age by secreted molecules from the LPS-activated microglia
localized in the upper transwell dishes. Using this coculture
system for 48 hours, the neuron became damaged according
to Neher et al., [23, 24]. WT and STIM1−/− microglia were
treated with LPS for 24 hours to full activation. Activated
WT and STIM1−/− microglia were treated directly in contact
with the damaged neuron to allow phagoptosis, for six hours.
The same number of microglia in the same number of
damaged neurons were used, and no activated microglia
treated neurons were used as mocks. After six hours, all
cells were fixed with 3.7% formaldehyde in the PBS, then
immunostaining was performed as above. Cells were also
stained with DAPI (for nuclei, blue), tomato lectin (for
microglia, Rhodamine-red), and MAP (for neuron, FITC-
green), respectively. The phagocytosis activity was relatively
analysed with the portion of the fully enlarged microglia cell
number (>35 𝜇m2) from the total number of the activated
microglia (>25 𝜇m2). The relative neuron survival rate from
the microglial phagoptosis was summarized by calculating
each MAP (FITC) staining intensity from the remaining
neurons in the five randomly selected images from the fields.
No microglia treated only neurons were used for mocks to
compare their phagoptosis activities.
2.10. Statistical Analyses. Data are presented as the means
± standard error of the mean. Statistical analysis was per-
formed with Student’s 𝑡-test or with analysis of variance
(ANOVA), followed by Tukey’s multiple comparison tests
using the GraphPad Prism software package (version 5.0), as
appropriate. 𝑝 < 0.05 was considered statistically significant.
3. Results
3.1. LPS-Stimulated Phagocytosis and Cytokine Secretion in
WT and STIM1−/−Microglia. Thebasal characteristics ofWT
and STIM1−/−microgliawere confirmedbefore using them for
further experiments (Supplementary Figures 1∼3 in Supple-
mentary Material available online at https://doi.org/10.1155/
2017/8158514). LPS is a potent immune activator of microglia,
which binds and activates TLR4 receptor signalling [25].
STIM1 effect on microglial immune function, phagocytic
activity, and cytokine secretion was compared in WT and
STIM1−/− microglia. To compare phagocytosis activity in
Mediators of Inflammation 5
WT mock
WT 100ng LPS STIM1−/− 100ng LPS
STIM1−/− mock
50𝜇m50𝜇m
50𝜇m 50𝜇m
(a)
∗
∗ ∗ ∗
WT STIM1−/−
LPSMock LPSMock
0
1
2
3
Re
lat
iv
e p
ha
go
cy
to
sis
 ac
tiv
ity
 (f
ol
d 
of
 W
T 
co
n)
(b)
∗ ∗ ∗
ns
WT
LPSMock LPSMock
STIM1−/−
0
200
400
600
800
𝛼
(p
g/
m
L)
Se
cr
et
io
n 
of
 T
N
F-
(c)
∗ ∗ ∗
STIM1−/−
ns
0
100
200
300
400
500
LPSMock LPSMock
WT
6
(p
g/
m
L)
Se
cr
et
io
n 
of
 IL
-
(d)
Figure 1: Lipopolysaccharide-induced phagocytosis and cytokine secretion inwild-type and STIM1−/−microglia. (a, b) Representative images
of image-based phagocytosis measurement using phagocytic engulfment of FITC bead in WT and STIM1−/− microglia. Summary of five
independent phagocytosis measurements. Seven images were used for phagocytosis measurements and then depicted as a bar graph. ∗∗∗𝑝 ≤
0.0001 in LPS-induced fold-induction ofWT; ∗𝑝 ≤ 0.005 inWTmock, 𝑛 = 7. (c, d) Comparisons of LPS-induced cytokine secretion activity:
TNF-𝛼 secretion (c) and IL-6 secretion (d) were compared inWT and STIM1−/− microglia. 𝑝 ≤ 0.0001, 𝑛 = 4, where 𝑛 is independent ELISA
experiment; ns, no significant difference fromWTmock.
WT and STIM1−/− microglia, resting and LPS-stimulated
(100 ng/mL for 24 h) phagocytotic activities were tested with
engulfment of E. coli opsonised FITC-labelled bioparticles.
Microglial cells were treated with bioparticle beads for 2 h.
Then, free beads and attached beads on the cell surface were
quenched by trypan blue, and cells were visualised using
fluorescence microscopy (Figures 1(a) and 1(b)). STIM1−/−
microglia under resting-state conditions showed a slight
reduction in phagocytotic activity. InWTcells, LPS treatment
for 24 h increased phagocytic activity by approximately 2.5-
fold, but STIM1−/− microglia had smaller increases in phago-
cytic activity. These results indicate that the LPS-stimulated
greater phagocytotic activity was more obviously found in
WT microglia. Next, we compared LPS-induced secretion of
TNF-𝛼 and IL-6 cytokines (Figures 1(c) and 1(d)).The results
show that STIM1−/− microglia secreted less than or equal to
half of the amount of TNF-𝛼 and IL-6, as that secreted byWT
microglia. These data indicate that STIM1 depletion reduces
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Figure 2: Comparison of UDP-induced Ca2+ signalling and phagocytosis in wild-type and STIM1−/− microglia. (a) Representative curves of
UDP-induced [Ca2+]i mobilization inWT and STIM1−/−microglia; 100 𝜇MUDP induced ER-Ca2+ efflux, whilst store depletion induced Ca2+
influx. (b) Relative UDP-induced Ca2+ transient release from ER. ∗∗∗𝑝 ≤ 0.0001, 𝑛 = 15. (c) Comparison of UDP-induced SOCE activity
determined by the slope of Ca2+ influx. ∗∗∗𝑝 ≤ 0.0001, 𝑛 = 15. (d) Representative flow cytometry images of the phagocytosis measurements.
FITC intensities of phagocytic bead engulfment with or without 100 𝜇MUDPwere measured at 20min. Grey region indicates the population
of bead-engulfedmicroglia. (e) Summary of FACS from three independent phagocytosis experiments. Geometricmean represents the relative
phagocytosis activity in each set. ∗∗𝑝 ≤ 0.001 in comparisons of bead engulfment in WT microglia.
phagocytotic activity and cytokine section in the microglia
under LPS-stimulation conditions.
3.2. UDP-Induced Phagocytosis Is Impaired in STIM1−/−
Microglia. Phagocytosis of microglia is activated by UDP
through P2Y6, metabotropic receptor that is coupled to the
Gq-protein [10]. RT-PCR analysis indicated that microglia
expresses P2X3, P2X4, and P2X7 receptors and all types of
P2Y receptors (Supplementary Figure 4). In particular, the
expression of P2Y receptors were somewhat increased in
STIM1−/− microglia, which implies that the compensatory
up-regulation of P2Y receptors might exist to cope with the
reduced Ca2+ influxes in STIM1−/− microglia. We measured
UDP-induced [Ca2+]i in WT and STIM1−/− microglia (Fig-
ure 2(a)). In STIM1−/− microglia, 100 𝜇M UDP induced a
transient increase in [Ca2+]i but no sustained Ca
2+ influx
(Figures 2(a)–2(c)). This result indicates that UDP-induced
calcium influx is almost disappeared in STIM1−/− microglia.
To more precisely test the microglial phagocytosis activity,
we tested the phagocytotic engulfment of E. coli opsonised,
FITC-labelled bioparticles using FACS (Figures 2(d) and
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Figure 3: Chemotactic migration in wild-type and STIM1−/− microglia. (a) Treatment with 50 𝜇M ATP-induced [Ca2+]i changes in 2mM
Ca2+ media. (b) Time-dependent migration toward 50 𝜇MATP determined in chemotaxis chambers. Cells migrating toward ATP were fixed,
stained with DAPI, and counted after 15, 30, 60, and 90min. The numbers of migrating cells at each time point were determined from six
independent experiments and are depicted graphically. ∗𝑝 ≤ 0.05, ∗∗𝑝 ≤ 0.001, and ∗∗∗𝑝 ≤ 0.0001 versus the corresponding control (𝑛 = 6,
where 𝑛 is the number of independent experiments).
2(e)). This method enabled discrimination of the UDP-
induced phagocytosis peak from the basal phagocytosis
peak. After phagocytotic bead engulfment for 20min with
or without UDP, microglia were detached by trypsin, and
collected cells were counted by FACS. Figure 2(d) shows the
representative FACS images of WT and STIM1−/− microglia.
Phagocytosis activity of WT and STIM1−/− microglia after
20min of UDP treatment is presented in Figure 2(e). UDP-
induced phagocytosis in STIM1−/− microglia was severely
defected compared to that in WT. These data indicate that
STIM1 is critically important in UDP-induced phagocytosis.
3.3. Chemotactic Migration Is Severely Defective in STIM1−/−
Microglia. ATP is a chemoattractant of microglia, and ATP
concentrations of approximately 50–100𝜇M activate several
purinergic receptors [12, 26]. First, we monitored [Ca2+]i by
measuring Fura-2-AM fluorescence under the same condi-
tions that were used for chemotactic migration experiments.
STIM1−/−microglia had a reduced Ca2+ evocation signal than
WT microglia (Figure 3(a)). Next, chemotactic migration to
ATP in chemotaxis chambers inWT and STIM1−/− microglia
was compared. The number of cells migrating into the
ATP chamber after 15, 30, 60, and 90min were counted
after DAPI staining. WT microglial migration was time-
dependent and increased with longer incubation times. By
contrast, STIM1−/− microglia did not show a time-dependent
increase in migration, and the number of cells migrating into
the ATP chamber was one-third of that for WT microglia.
These results clearly indicate that STIM1−/− microglia have
defective chemotactic migration to ATP (Figure 3(b)). These
data show that STIM1 is crucial for microglial chemotactic
migration activity.
3.4. Peripheral/Central Localization of Orai1 Is Controlled
by STIM1 upon UDP Stimulation. We supposed that Orai1
is a microdomain indicator of [Ca2+]i, since Ca
2+ influxes
through Orai1 which can change [Ca2+]i underneath the
plasma membrane and build a microdomain of [Ca2+]i. To
test whether the peripheral localization of Orai1 was con-
trolled by STIM1, we compared localization of Orai1 under
UDP treatment which induce acute phagocytic movement
in WT and STIM1−/− microglia [27]. At the resting state,
Orai1 was merely found at the cell periphery. After 40min of
UDP treatment, Orai1 clusters in the peripheral region were
significantly increased, and some of them were colocalized
with STIM1 clusters in WT microglia (Figure 4(a)). Such
clusters of Orai1 in peripheral regions were not observed
in STIM1−/− microglia (Figure 4(b)). These results suggested
that STIM1 regulates Orai1 localization upon UDP treated
conditions, and it might imply that STIM1 controls [Ca2+]
microdomains in the cell periphery that requires for local
Ca2+ signalling for phagocytic or chemotactic migration
movements.
3.5. Microglial Aggregation in LPS-Injected Lesions Was Abol-
ished in STIM1−/− Embryonic Brain. To test the in vivo
behaviour ofmicroglia, we injected 30 nL LPS plusmethylene
blue mix into brains of 17-day-old embryos impregnated
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Figure 4: Retarded peripheral localization of Orai1 in STIM1−/− microglia upon UDP stimulation. UDP induces movement of Orai1 (green)
and STIM1 (red) in WT microglia (a) and STIM1−/− microglia (b), respectively. Treatment with 100 𝜇M UDP for 40min increased Orai1
localization at the cell surface throughout the cell border in WT(a) and STIM1−/− microglia (b). Insets were magnified following separated
three (a) or one image (b). Orai1-FITC-intensity profiles in red lined regions were shown in each of the rightmost images. The cell border is
indicated by dotted lines. Clustered Orai1 in peripheral regions of WTmicroglia were indicated by white arrows, and the absence of Orai1 in
peripheral regions of STIM1−/− microglia was indicated by black arrows. (c) Intensity of surface Orai1 in cell periphery was compared with
the UDP condition. Intensity of surface Orai1 in cell periphery was determined by the intensity of ROI with 0.65𝜇m away from the cell edges,
using MetaMorph software.
in STIM1+/− female mice mated with STIM1+/− male mice.
Methylene blue was used to label the injection site in the tis-
sue slices. At 24 h after injection, each embryo brain was har-
vested and their genotypes were checked. WT and STIM1−/−
brains were sectioned, and the sections containing lesions
labelled with methylene blue were selected and stained with
Iba1 to visualisemicroglia. Two sets of representativeWT and
STIM1−/− brain tissue sections at different magnifications are
presented in Figure 5(a). InWTbrain, Iba1-labelledmicroglia
aggregated at the LPS-methylene blue injected lesion, but the
counterpart region of the noninjected hemisphere displayed
normal ramified microglia. High-magnification images of
both hemispheres clearly show their distinct morphologies
as ramified resting state, and amoeboid activated state. In
STIM1−/− brain tissue, the LPS-methylene blue injected lesion
was not crowded with microglia, and the microglia localized
in the lesion showed similar amoeboid shapes as those ofWT.
We calculated the total microglial cell number in the whole-
brain slices, and did not find any significant difference in the
cell numbers as shown in mocks in STIM1−/− brain tissue.
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Figure 5: In vivo behaviour of microglia in lipopolysaccharide-injected brains of wild-type and STIM1−/− embryonic mice. (a) Two
experimental sets representing microglial aggregation at the site of injection of LPS and methylene blue (MB) in WT and STIM1−/− mice
brain. No LPS injection (upper right hemisphere) and LPS-injected (lower left hemisphere) are indicated in low-magnification images of
immunostaining with Iba1 antibody (A, F, K, and P; bar = 500𝜇m). White boxed regions are twofold magnifications ((B, D, G, I, L, N, Q,
and S; bar = 50 𝜇m) and (C, E, H, J, M, O, R, and T; bar = 10 𝜇m)). Merged images of green Iba1-FITC and grey-DIC are shown in B–E, G–J,
L–O, and Q–T; microglia are shown in green and methylene blue particles are shown in grey. Resting ramified microglia (C, H, M, and R)
were identified in the noninjected hemisphere, and the stimulated amoeboid shapes of microglia engulfing methylene blue particles (E, J, O,
and T) were identified only in the LPS + MB injected region. (b) Comparison of aggregated microglial numbers at the LPS injection site.
The numbers of microglia at the LPS + MB injection hemisphere and noninjected hemisphere were counted. ∗𝑝 ≤ 0.05; ∗∗𝑝 ≤ 0.01; ns, no
significant difference fromWTmock. Data are representative of three experiments.
10 Mediators of Inflammation
These results also were observed when the number of cells
after primary culture of each mouse was counted. However,
STIM1−/− brain slices had definitely reduced numbers of
Iba1 positive microglia aggregated in LPS-injected lesions
(Figure 5(b)), which indicates that STIM1−/− microglia have
a defect in migration activity toward the legion.These in vivo
data indicate that STIM1−/− microglia have severe defects in
chemotactic migration activity in brain environment.
3.6. Neuron Phagocytosis Activity Is Attenuated in STIM1−/−
Microglia. To compare themicroglial phagocytosis activities,
we tested the phagocytic activity of WT and STIM1−/−
microglia in the condition of direct contact with damaged
cortical neurons. Since the LPS treatment without microglia
does not cause damage of neuron [24], we applied the
coculture systems using WT microglia with 100 ng/mL LPS
treatment on transwell inserts, and the primary cultured
cortical WT neurons on the bottom of the plate for two days
to prepare for the phosphatidylserine- (PS-) exposed WT
neuron [24]. After two days, the transwell insert was removed
and the medium was also washed out, and preactivated
(100 ng/mL LPS for 24 h) WT or STIM1−/− microglia were
directly added to PS-exposed damaged neuronal cells [23].
After 6 h, the cortical neuron and microglia cells were
fixed and cells were indicated with corresponding antibodies
(Figures 6(a) and 6(b)). We analysed each size of tomato
lectin positive microglia cells, and counted the fully enlarged
microglia engulfing neurons. The total number of fully
enlarged microglia (>35 𝜇m2) out of the total number of
activated microglia (>25 𝜇m2) was significantly higher in
WT microglia (Figure 6(c)). These data indicated that LPS-
activated WT microglia had higher neuron phagocytosis
activities than STIM1−/− microglia. Furthermore, the neu-
ronal survival rate from phagoptosis by STIM1−/− microglia
wasmuch higher than that ofWTmicroglia (Figure 6(d)). All
of the data suggests that STIM1 is important in phagoptosis
activities of microglia.
4. Discussion
One of the most crucial signalling pathways during immune
cell differentiation is sustained calcium elevation in the
cytosol, which is mediated primarily by SOCE [14]. The
significance of SOCE was demonstrated in studies using
pharmacological inhibitors and depletion of extracellular
calcium with calcium chelators, but it has not been fully
evaluated inmicroglial cells under completely blocked condi-
tions until STIM1 was identified [15, 20]. Complete depletion
of SOCE was necessary to determine whether the complete
SOCE depletion abolished immune response activation of
immune responses, which is mediated by sustained [Ca2+]i
increase in response to several agonists. A complete depletion
of SOCE was achieved in purified lymphocytes of STIM1−/−
mice, including mast cells, T cells, platelets, neutrophils, and
microglia [20, 28–32]. Our previous using siRNA for STIM1
was not able to completely deplete all STIM1 protein, so
the effect of residual STIM1 in activated immune function
of microglia could not be ruled out [33]. In this study, we
evaluate the in vitro and in vivo effects of STIM1-regulated
SOCE onmicroglial immune functions including phagocyto-
sis, cytokine secretion, and chemotactic migration. Not only
the Ca2+ signal which changes the profile or efficiency of gene
expression, but also the Ca2+ signal which acutely regulates
the function such as UDP-induced phagocytosis and ATP-
induced chemotaxis was significantly decreased in STIM1
depletion condition.
STIM2 was less effective to activate SOCE than STIM1 in
T cells [14, 28] and microglia [32]. Michaelis et al. recently
reported that STIM2−/− microglia displayed SOCE activation
by store depletion and nucleotide stimulation, comparedwith
the complete absence of SOCE in STIM1−/− microglia [32].
Western blot analyses and [Ca2+]i measurements indicated
that STIM1 protein expressionwas greater than that of STIM2
(Supplementary Figure 1B). SOCE was essentially abolished
after CPA-induced Ca2+ depletion from ER in STIM1−/−
microglia (Supplementary Figures 2A and 2D) in spite of
the presence of STIM2 (Supplementary Figure 1B). These
results indicate that STIM1 is the major regulator of SOCE
in microglia.
Important roles of STIM1 in differentiation of active
microglial status were proved by attenuated immune func-
tion of activated microglia treated with LPS. LPS-induced
activated microglia showed increased phagocytosis activity
and cytokine secretion of TNF−𝛼 and IL-6, but those were
significantly reduced in STIM1−/− microglia. The sustained
high [Ca2+]i via Ca
2+ influx causes the change of Ca2+ con-
centration of nucleus which yields the change of gene expres-
sion for fully differentiation [14]. These reduced chronic
immune function of STIM1−/− microglia might be caused by
the reduced Ca2+ influx and lower [Ca2+]i status, which abol-
ishes the increase of nuclear Ca2+ concentration to change
the gene expression for fully differentiation. Moreover, the
crucial role of STIM1 in acute movement was proved by
UDP-induced phagocytosis and ATP-stimulated chemotaxis.
The UDP-induced phagocytosis is relatively faster function
which demands the cytoskeletal movement governed by
local Ca2+ signal in the cell periphery [10]. The markedly
impaired UDP-induced phagocytosis in STIM1−/− microglia
seems to be caused by local increased Ca2+ concentration
right after the influx. Similarly, ATP-stimulated microglial
chemotaxis and migration were greatly reduced in STIM1−/−
microglia subjected to chemotaxis assays. Time-dependent
ATP-stimulated cell migration was essentially abolished in
STIM1−/− microglia (Figure 3(b)). These defects might be
related with the retarded movement of Orai1 in STIM1−/−
microglia (Figure 4). Orai1 pores can constitute a [Ca2+]
microdomain underneath the plasmamembrane through the
Ca2+ influx. Attenuated movements of Orai1 in STIM1−/−
microglia implied that STIM1 is critical for the organization
of [Ca2+] microdomains in microglia.
This in vitro result was confirmed in in vivo studies.
The cell migration to the injured site was severely impaired
in the brain environment (Figure 5) and damaged neuron
phagoptosis was much more retarded in STIM1−/− microglia
(Figure 6). Injured cells release nucleotides such as ATP,
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Figure 6: Decreased neuron phagoptosis activity of STIM1−/− microglia. (a) Neuron phagoptosis by WT microglia was shown by
immunostaining of neuron and microglia after damaging neuron and LPS-activated WT microglia (bar = 200𝜇m). Normal neurons were
stained with MAP specific antibodies (green), and WT microglia were stained with tomato lectins (red). The second image shows enlarged
microglia indicated via arrows.The third image shows highlymagnified images of the activatedmicroglia engulfing neurons, soMAP staining
was found inside of themicroglia stained with tomato lectin. (b) Similar image to the above, but used LPS-activated STIM1−/−microglia which
coexisted with neurons. The second image shows some enlarged STIM1−/− microglia indicated with arrows. The third image shows highly
magnified images showing the activatedmicroglia near the neurons. (c)The relative size of the activatedWTand STIM1−/−microglia indicated
via bar graph. 25 𝜇m2 was determined as the minimum size of activated microglia, and the number of cells bigger than 35 𝜇m2 was assigned
as the “fully enlarged microglia engulfing neuron,” which is significantly small in STIM1−/− microglia population. ∗∗∗𝑝 ≤ 0.001. 𝑛 ≥ 100;
𝑛 = cell number from 3 independent experiments. (d) The relative neuron survival rate was analysed using MAP2 staining intensity of the
remaining neuron after 6 hr phagoptosis, in which images were delivered from five randomly selected fields of leftmost images. Each of the
phagoptosis activities was compared with the total MAP2 intensity of the only neuron which was without phagoptosis by activated microglia.
∗∗∗𝑝 ≤ 0.001, ∗𝑝 ≤ 0.05, 𝑛 ≥ 15, and 𝑛 = 5 images from 3 independent experiments.
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which is a known chemotactic attractant and an activator
of purinergic receptors such as P2X4 and P2Y12, and rapid
cell migration is essential for microglial recruitment to the
site of brain lesions [12, 13]. Although the severe impairment
of cell migration in STIM1−/− embryonic brain is not only
due to defective chemotaxis of STIM1−/− microglia, since
the environment of STIM1−/− brains is also differs from
that of WT brains in our experimental conditions. How-
ever, defective chemotaxis of STIM1−/− microglia in vitro
and retarded phagocytosis activity toward damaged neurons
strongly suggest that STIM1 is essential for regulating chemo-
tactic migration and phagocytosis activated by chemical cue
or damaged neurons.
Cell migration is coordinated by Ca2+ signalling, in
part through local Ca2+ signalling in the cell leading edge
[9]. Previous reports have identified STIM1 localization in
podosome [34], phagosome [34], and cell-matrix adhesion
at the front of migrating cells [9]. Recent work showed
that receptor tyrosine kinase signalling and phospholipase
C signalling are restricted to the front of the migrating
endothelial leader cells, which triggers local Ca2+ pulses,
local depletion of ER-Ca2+, and local STIM1 activation; these
cascades orchestrate pulsatile retraction and adhesion of the
leading cell front [9]. Another study reported that STIM1
localization is juxtaposed to ER and phagosomes, which
generate Ca2+ hotspots that boost phagocytosis [7]. Our
results are in agreement with these previous studies that
STIM1-regulated local Ca2+ influx in the leading focal adhe-
sion microdomain is important for the function mediated
by local cytoskeletal rearrangement, such as UDP-induced
rapid phagocytosis and ATP-induced chemotactic migration.
Notably, STIM1 depletion had a stronger adverse effect on the
rate of UDP-induced rapid phagocytosis and ATP-induced
chemotacticmigration (Figures 2(d), 2(e), and 3(b)) than that
on activation of LPS-induced phagocytotic activity (Figures
1(a) and 1(b)) and LPS-induced cytokine secretion (Figures
1(c) and 1(d)). These data might imply that the role of STIM1
in local Ca2+ microdomains is more critical than the role of
STIM1 in [Ca2+]i change through the cells.
A recent study indicated that STIM1 inhibition in lym-
phocytes had beneficial effects for anaphylactic responses
[20], ischemic brain infarction [30], and autoimmune disease
[31]. The current model of neuronal degeneration considers
that inflamed microglia have detrimental effects that lead
to neuronal loss [2]. The retarded LPS-induced activation
of STIM1−/− microglia implied that inhibition of STIM1 can
attenuate the magnitude of flammability of microglia. Our
result showed that STIM1−/−microglia has reduced phagopto-
sis activity toward damaged neurons (Figure 6).These results
suggest that STIM1 can be used as a new therapeutic target to
prevent the excessive immunological microglial function and
thereby delay the progression of neurodegenerative diseases.
In conclusion, we found that STIM1−/− microglia showed
reduced cytokine secretion and opsonin-dependent phago-
cytosis in LPS condition. More importantly, UDP-induced
phagocytosis and ATP-stimulated chemotactic migration
were severely impaired in STIM1−/− microglia in vitro and
in vivo. These results suggest that STIM1-mediated store-
operated calcium entry is also important for the regulation of
global [Ca2+]i changes, but it is indispensable for regulating
local [Ca2+] microdomains in murine microglia.
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